IgA nephropathy: open trials in Greece

2 open trials have a site in Greece. Registry data; only the trial team decides who can take part.

2024-519638-22-00
A clinical trial to learn about the long-term safety of FUB523 (zigakibart) in people with immunoglobulin A (IgA) nephropathy who have completed previous zigakibart trials
Trial Treatment · Phase 3 · Novartis Pharma AG
University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · General Hospital of Ioannina G. Hatzikosta, Ioannina · General Hospital Of Thessaloniki Agios Pavlos, Kalamaria · General University Hospital Of Patras, Patras · University General Hospital of Thessaloniki - AHEPA, Thessaloniki
Registry updated 2026-10-30
NCT06935357
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
Trial Treatment · Phase 3 · Biogen
General Hospital of Arta, Arta · General Hospital of Athens "G. Gennimatas", Athens · Hippokration Hospital, Athens · Laiko General Hospital of Athens, Athens · University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · University General Hospital of Heraklion, Heraklion · University General Hospital of Ioannina, Ioannina · General University Hospital Of Patras, Patras · University General Hospital of Thessaloniki - AHEPA, Thessaloniki · Geniko Nosokomeio Thessalonikis George Papanikolaou, Thessaloniki
Registry updated 2026-10-14

This page is not medical advice. Talk to your doctor before contacting a trial.

A clinical trial to learn about the long-term safety of FUB523 (zigakibart) in people with immunoglobulin A (IgA) nephropathy who have completed previous zigakibart trials